Results 221 to 230 of about 22,306,541 (256)

Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside

Advanced Drug Delivery Reviews, 2020
Alberto Gabizon
exaly  

Mitomycin C

2012
openaire   +1 more source

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial

Lancet Oncology, The, 2011
Savino M Di Stasi, Marco Valenti, Francesco Masedu   +2 more
exaly  

Delayed hypersensitivity to Mitomycin C

Contact Dermatitis, 2009
D Gutierrez, Fernandez, A Foncubierta, Fernández, M S Fuentes, Vallejo, J L Alvarez, Osorio, M J Fernández, Anguita, A Leon, Jimenez   +5 more
openaire   +2 more sources

Mitomycin C

2008
openaire   +1 more source

Mitomycin C

2010
Ines Mader, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer   +4 more
openaire   +1 more source

Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer

Nature reviews. Urology, 2014
H. Zargar, J. Aning, J. Ischia, A. So, P. Black   +4 more
semanticscholar   +1 more source

Controlled release of Mitomycin C from modified cellulose based thermo-gel prevents post-operative de novo peritoneal adhesion

Carbohydrate Polymers, 2020
Tamanna Sultana, Byong-Taek Lee
exaly  

Mitomycin C.

Cancer chemotherapy and biological response modifiers, 1992
N W, Gibson, D, Siegel, D, Ross
openaire   +1 more source

Ocular Toxicity of Mitomycin-C

International Ophthalmology Clinics, 1999
D R, Hardten, T W, Samuelson
openaire   +2 more sources